Inventor · disambiguated record
Takako Okumura
Also filed as: OKUMURA TAKAKO
13 granted patents·5 pending applications·54 citations·filing 2010–2023
90Inventor score
Top patents by PatentIndex Score
18 records- 0193US10947235B2Selective EP4 receptor antagonistic substance for treatment of cancerASKAT INC·Filed 2020·Granted Mar 16, 2021·3 cites·12 claims
- 0293US10611761B2Selective EP4 receptor antagonistic substance for treatment of cancerASKAT INC·Filed 2017·Granted Apr 7, 2020·7 cites·20 claims
- 0393US9688674B2Selective EP4 receptor antagonistic substance for treatment of cancerRAQUALIA PHARMA INC·Filed 2014·Granted Jun 27, 2017·7 cites·6 claims
- 0490US8921391B2Selective EP4 receptor antagonistic substance for treatment of cancerTAKE YUKINORI·Filed 2010·Granted Dec 30, 2014·13 cites·8 claims
- 0588US10583129B2Use of EP4 receptor antagonists for the treatment of NASH-associated liver cancerASKAT INC·Filed 2019·Granted Mar 10, 2020·5 cites·8 claims
- 0686US10342785B2Use of EP4 receptor antagonists for the treatment of NASH-associated liver cancerASKAT INC·Filed 2016·Granted Jul 9, 2019·4 cites·24 claims
- 0784US10391086B2Use of EP4 receptor antagonists in the treatment of cartilage diseaseASKAT INC·Filed 2018·Granted Aug 27, 2019·2 cites·8 claims
- 0883US9447066B2Salts and crystal formsASKAT INC·Filed 2014·Granted Sep 20, 2016·8 cites·11 claims
- 0980US10973834B2EP4 inhibitors and use thereofARRYS THERAPEUTICS INC·Filed 2019·Granted Apr 13, 2021·3 cites·20 claims
- 1074US11840530B2Selective EP4 receptor antagonistic substance for treatment of cancerASKAT INC·Filed 2021·Granted Dec 12, 2023·0 cites·21 claims
- 1167US2024066040A1Ep4 inhibitors and use thereofARRYS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1266US9457084B2Use of EP4 receptor antagonists in the treatment of IL-23 mediated diseasesKANAZAWA KIYOSHI·Filed 2011·Granted Oct 4, 2016·2 cites·1 claims
- 1360US10786490B2Use of EP4 receptor antagonists in the treatment of cartilage diseaseASKAT INC·Filed 2017·Granted Sep 29, 2020·0 cites·7 claims
- 1457US2021290641A1Ep4 inhibitors and use thereofARRYS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1553US9561210B2Therapeutic agent for ocular diseaseASKAT INC·Filed 2014·Granted Feb 7, 2017·0 cites·4 claims
- 1651US2016317514A1Use of ep4 receptor antagonists in the treatment of cartilage diseaseASKAT INC·Filed 2014·Application pending·0 cites
- 1739US2019365680A1Use of ep4 receptor antagonists for the treatment of nash-associated liver cancerASKAT INC·Filed 2017·Application pending·0 cites
- 1839US2021353648A1Grapiprant unit dosage formsARRYS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →